Neuromyelitis optica spectrum disorders in Iran

Multiple Sclerosis and Related Disorders

Volumn 18, Issue , 2017, Pages 209-212

  Eskandarieh, Sharareh ^a,b   Nedjat, Saharnaz ^c   Azimi, Amir Reza ^b   Moghadasi, Abdorreza Naser ^b   Sahraian, Mohammad Ali ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clinical feature; Epidemiology; Neuromyelitis optica spectrum disorder; Prevalence

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ARTICLE; CAUCASIAN; CLINICAL FEATURE; CONSENSUS; CROSS-SECTIONAL STUDY; DEPRESSION; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; HYPOTHYROIDISM; IRAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIGRAINE; MYELOOPTIC NEUROPATHY; ONSET AGE; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SEROLOGY; SEX RATIO; STRUCTURED INTERVIEW; SYMPTOM; YOUNG ADULT; ADOLESCENT; AGE; COMORBIDITY; METABOLISM; PATHOPHYSIOLOGY; SEX FACTOR;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IRAN; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; PREVALENCE; SEX FACTORS; YOUNG ADULT;

EID: 85031312128     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2017.10.007     Document Type: Article

References (35)

1. Abdollahpour, I., Nedjat, S., Sahraian, M.A., Mansournia, M.A., Otahal, P., van der Mei, I., Waterpipe smoking associated with multiple sclerosis: a population-based incident case-control study. Mult. Scler., 2016 (1352458516677867).
2. Alamdari, S., Amouzegar, A., Tohidi, M., Gharibzadeh, S., Kheirkhah, P., Kheirkhah, P., et al. Hypothyroidism and lipid levels in a community based study (TTS). Int. J. Endocrinol. Metab., 14(1), 2016, e22827.
3. Asgari, N., Lillevang, S.T., Skejoe, H.P., Falah, M., Stenager, E., Kyvik, K.O., A population-based study of neuromyelitis optica in Caucasians. Neurology 76:18 (2011), 1589–1595.
4. Ashtari, F., Safaei, A., Shaygannejad, V., Najafi, M.A., Vesal, S., Neuromyelitis Optica Spectrum Disease Characteristics in Isfahan, Iran: A Cross-sectional Study. J Res Med Sci, 22, 2017, 41.
5. Bizzoco, E., Lolli, F., Repice, A.M., Hakiki, B., Falcini, M., Barilaro, A., et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J. Neurol. 256:11 (2009), 1891–1898.
6. Cabre, P., Heinzlef, O., Merle, H., Buisson, G.G., Bera, O., Bellance, R., et al. MS and neuromyelitis optica in Martinique (French West Indies). Neurology 56:4 (2001), 507–514.
7. Cabre, P., Gonzalez-Quevedo, A., Lannuzel, A., Bonnan, M., Merle, H., Olindo, S., et al. Descriptive epidemiology of neuromyelitis optica in the Caribbean basin. Rev. Neurol. 165:8–9 (2009), 676–683.
8. Cabrera-Gomez, J.A., Kurtzke, J.F., Gonzalez-Quevedo, A., Lara-Rodriguez, R., An epidemiological study of neuromyelitis optica in Cuba. J. Neurol. 256:1 (2009), 35–44.
9. Chavarro, V.S., Mealy, M.A., Simpson, A., Lacheta, A., Pache, F., Ruprecht, K., et al. Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder. Neurol. Neuroimmunol. Neuroinflamm., 3(6), 2016, e286.
10. Cossburn, M., Tackley, G., Baker, K., Ingram, G., Burtonwood, M., Malik, G., et al. The prevalence of neuromyelitis optica in South East Wales. Eur. J. Neurol. 19:4 (2012), 655–659.
11. Eskandarieh, S., Heydarpour, P., Minagar, A., Pourmand, S., Sahraian, M.A., Multiple sclerosis epidemiology in East Asia, South East Asia and South Asia: a systematic review. Neuroepidemiology 46:3 (2016), 209–221.
12. Eskandarieh, S., Nedjat, S., Abdollahpour, I., Moghadasi, A.N., Azimi, A.R., Sahraian, M.A., Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: a case-control study. Mult. Scler. Relat. Disord. 12 (2017), 39–43.
13. Eskandarieh, S., Heydarpour, P., Elhami, S.R., Sahraian, M.A., Prevalence and incidence of multiple sclerosis in Tehran, Iran. Iran. J. Public Health 46:5 (2017), 699–704.
14. Etemadifar, M., Dashti, M., Vosoughi, R., Abtahi, S.H., Ramagopalan, S.V., Nasr, Z., An epidemiological study of neuromyelitis optica in Isfahan. Mult. Scler. 20:14 (2014), 1920–1922.
15. Etemadifar, M., Nasr, Z., Khalili, B., Taherioun, M., Vosoughi, R., Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis. Mult. Scler. Int., 2015, 2015, 174720.
16. Fazio, R., Malosio, M.L., Lampasona, V., De Feo, D., Privitera, D., Marnetto, F., et al. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients. Mult. Scler. 15:10 (2009), 1153–1163.
17. Horton, M., Rudick, R.A., Hara-Cleaver, C., Marrie, R.A., Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology 35:2 (2010), 83–90.
18. Houzen, H., Niino, M., Hirotani, M., Fukazawa, T., Kikuchi, S., Tanaka, K., et al. Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan. J. Neurol. Sci. 323:1–2 (2012), 117–122.
19. Jacob, A., Panicker, J., Lythgoe, D., Elsone, L., Mutch, K., Wilson, M., et al. The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom. J. Neurol. 260:8 (2013), 2134–2137.
20. Jarius, S., Ruprecht, K., Wildemann, B., Kuempfel, T., Ringelstein, M., Geis, C., et al. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J. Neuroinflamm., 9, 2012, 14.
21. Jarius, S., Ruprecht, K., Kleiter, I., Borisow, N., Asgari, N., Pitarokoili, K., et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J. Neuroinflamm., 13(1), 2016, 279.
22. Kashipazha, D., Mohammadianinejad, S.E., Majdinasab, N., Azizi, M., Jafari, M., A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran. Iran. J. Neurol. 14:4 (2015), 204–210.
23. Kim, S.M., Woodhall, M.R., Kim, J.S., Kim, S.J., Park, K.S., Vincent, A., et al. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol. Neuroimmunol. Neuroinflamm., 2(6), 2015, e163.
24. Pandit, L., Kundapur, R., Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India. Mult. Scler. 20:12 (2014), 1651–1653.
25. Pandit, L., Asgari, N., Apiwattanakul, M., Palace, J., Paul, F., Leite, M.I., et al. Demographic and clinical features of neuromyelitis optica: a review. Mult. Scler. 21:7 (2015), 845–853.
26. Rivera, J.F., Kurtzke, J.F., Booth, V.J., Corona VTt. characteristics of Devic's disease (neuromyelitis optica) in Mexico. J. Neurol. 255:5 (2008), 710–715.
27. Sahraian, M.A., Naghshineh, H., Shati, M., Jahromi, S.R., Rezaei, N., Persian adaptation of a questionnaire of environmental risk factors in multiple sclerosis (EnvIMS-Q). Mult. Scler. Relat. Disord. 10 (2016), 82–85.
28. Sharifi, V., Amin-Esmaeili, M., Hajebi, A., Motevalian, A., Radgoodarzi, R., Hefazi, M., et al. Twelve-month prevalence and correlates of psychiatric disorders in Iran: the Iranian Mental Health Survey, 2011. Arch. Iran. Med. 18:2 (2015), 76–84.
29. Turner, A.P., Alschuler, K.N., Hughes, A.J., Beier, M., Haselkorn, J.K., Sloan, A.P., et al. Mental health comorbidity in MS: depression, anxiety, and bipolar disorder. Curr. Neurol. Neurosci. Rep., 16(12), 2016, 106.
30. Waters, P., Reindl, M., Saiz, A., Schanda, K., Tuller, F., Kral, V., et al. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 87:9 (2016), 1005–1015.
31. Wingerchuk, D.M., Lennon, V.A., Pittock, S.J., Lucchinetti, C.F., Weinshenker, B.G., Revised diagnostic criteria for neuromyelitis optica. Neurology 66:10 (2006), 1485–1489.
32. Wingerchuk, D.M., Lennon, V.A., Lucchinetti, C.F., Pittock, S.J., Weinshenker, B.G., The spectrum of neuromyelitis optica. Lancet Neurol. 6:9 (2007), 805–815.
33. Wingerchuk, D.M., Banwell, B., Bennett, J.L., Cabre, P., Carroll, W., Chitnis, T., et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85:2 (2015), 177–189.
34. Yurkovich, M., Avina-Zubieta, J.A., Thomas, J., Gorenchtein, M., Lacaille, D., A systematic review identifies valid comorbidity indices derived from administrative health data. J. Clin. Epidemiol. 68:1 (2015), 3–14.
35. Zamvil, S.S., Slavin, A.J., Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder?. Neurol. Neuroimmunol. Neuroinflamm., 2(1), 2015, e62.